TY  - GEN
AU  - Lescaille,Géraldine
AU  - Coudert,Amélie E
AU  - Baaroun,Vanessa
AU  - Ostertag,Agnès
AU  - Charpentier,Emmanuel
AU  - Javelot,Marie-José
AU  - Tolédo,Rafael
AU  - Goudot,Patrick
AU  - Azérad,Jean
AU  - Berdal,Ariane
AU  - Spano,Jean-Philippe
AU  - Ruhin,Blandine
AU  - Descroix,Vianney
TI  - Clinical study evaluating the effect of bevacizumab on the severity of zoledronic acid-related osteonecrosis of the jaw in cancer patients
SN  - 1873-2763
PY  - 2014///0831
KW  - Antibodies, Monoclonal, Humanized
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bevacizumab
KW  - Bisphosphonate-Associated Osteonecrosis of the Jaw
KW  - drug therapy
KW  - Diphosphonates
KW  - adverse effects
KW  - Female
KW  - Humans
KW  - Imidazoles
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - Risk Factors
KW  - Treatment Outcome
KW  - Zoledronic Acid
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.bone.2013.10.002
ER  -